Kaye Edward M. MD

CIK 00015227804 companiesBEDFORD, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001522780

Recent Transactions

50 trades

Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2026-08-18$32.47/sh−637→ 124,557 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2026-08-18$32.01/sh−11,930→ 125,194 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2026-08-14+26,250→ 137,124 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Performance Stock Units
2026-08-14−26,250→ 0 total
Award
CYTOKINETICS INC$CYTK
Common Stock
2026-07-15$82.62/sh+151→ 10,434 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2026-06-03+17,786→ 17,786 total
Sale
CYTOKINETICS INC$CYTK
Common Stock
2026-06-01$76.09/sh−2,933→ 10,283 total
Award
CYTOKINETICS INC$CYTK
Common Stock
2026-05-27+2,851→ 13,216 total
Award
CYTOKINETICS INC$CYTK
Non-Qualified Stock Option (Right to Buy)
2026-05-27+4,301→ 4,301 total
Award
CYTOKINETICS INC$CYTK
Common Stock
2026-04-15$65.37/sh+191→ 10,365 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2026-03-15−35,500→ 35,500 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2026-03-15+26,250→ 110,874 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2026-03-15−26,250→ 52,500 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2026-03-15+35,500→ 84,624 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−10,034→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−22,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−9,534→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−13,489→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−15,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−22,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−11,323→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-02-27−6,692→ 0 total
Award
CYTOKINETICS INC$CYTK
Common Stock
2026-01-15$63.44/sh+197→ 10,174 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-08$31.44/sh−3,825→ 58,729 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-08$32.52/sh−8,274→ 50,455 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-08$33.10/sh−1,331→ 49,124 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-05$31.15/sh−1,681→ 63,054 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-05$31.33/sh−6,367→ 64,735 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-05$31.85/sh−500→ 62,554 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-04$30.76/sh−5,222→ 72,333 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-04$31.32/sh−1,231→ 71,102 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-03+26,250→ 77,555 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Performance Stock Units
2025-12-03−26,250→ 0 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-03$30.85/sh−651→ 51,305 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-03$30.34/sh−419→ 51,956 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-02$30.14/sh−405→ 52,375 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-02$29.56/sh−661→ 52,780 total
Sale
CYTOKINETICS INC$CYTK
Common Stock
2025-12-01$66.72/sh−28,064→ 9,977 total
Exercise/Conversion
CYTOKINETICS INC$CYTK
Non-Qualified Stock Option (Right to Buy)
2025-12-01−8,064→ 0 total
Exercise/Conversion
CYTOKINETICS INC$CYTK
Common Stock
2025-12-01$12.40/sh+8,064→ 18,041 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2025-12-01−4,317→ 0 total
Exercise/Conversion
CYTOKINETICS INC$CYTK
Common Stock
2025-12-01$14.25/sh+20,000→ 38,041 total
Exercise/Conversion
CYTOKINETICS INC$CYTK
Non-Qualified Stock Option (Right to Buy)
2025-12-01−20,000→ 0 total
Sale
CYTOKINETICS INC$CYTK
Common Stock
2025-11-11$65.08/sh−5,175→ 9,977 total
Exercise/Conversion
CYTOKINETICS INC$CYTK
Non-Qualified Stock Option (Right to Buy)
2025-11-11−5,175→ 0 total
Exercise/Conversion
CYTOKINETICS INC$CYTK
Common Stock
2025-11-11$9.66/sh+5,175→ 15,152 total
Award
CYTOKINETICS INC$CYTK
Common Stock
2025-10-15$62.80/sh+199→ 9,977 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Stock Option (Right to Buy)
2025-10-08−25,000→ 542,801 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-10-08$0.60/sh+25,000→ 74,124 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-10-08$30.00/sh−25,000→ 49,124 total

Companies

Recent Filings

Address

C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE

BEDFORD, MA, 01730

View on SEC.gov